Close mobile menu×
Close mobile menu

Nicole Lamanna, MD

Board Certifications: 
Medical Oncology
Expertise in: 
Leukemia, Cancer Care
Accepting New Patients
Profile Headshot

Appointments

Phone Appointments

New and Existing Patients: 
(212) 305-5098
New Patients: 
(212) 305-5098
Existing Patients: 
(646) 317-5077

myColumbiaDoctors

For existing patients, login to make an appointment, view documentation or contact your care provider.

Credentials & Experience

America's Top Doctor
NY Top Doctor

Board Certifications

  • Medical Oncology

Clinical Expertise

  • Cancer Care
  • Leukemia
  • Acute Leukemia
  • Acute Lymphocytic Leukemia
  • Acute Myelogenous Leukemia
  • Acute Myeloid Leukemia
  • Chronic Leukemia
  • Chronic Lymphoid Leukemia
  • Chronic Myelogenous Leukemia
  • Essential Thrombocythemia
  • Hairy Cell Leukemia
  • Hematologic Malignancy
  • Hemolytic Anemia
  • Waldenstrom's Macroglobulinemia
  • Polycythemia Vera
  • Myeloproliferative Disorder
  • Myelofibrosis
  • Myelodysplastic Syndrome
  • Large Granular Lymphocytic Leukemia
  • Immune Thombocytopenic Purpura
  • Chronic Lymphocytic Leukemia

Specialties

Education & Training

  • MD, Albert Einstein College Medicine
  • 1998 Albert Einstein College of Medicine
  • Residency: New York University Medical Center
  • Fellowship: Memorial Sloan-Kettering Cancer Center

About Nicole Lamanna

Biography - Dr. Nicole Lamanna

Nicole Lamanna, MD, is an Associate Clinical Professor of Medicine in the Hematologic Malignancies Section of the Hematology/Oncology Division. Dr. Lamanna is a hematologist/oncologist whose research interests include lymphoid leukemias, specifically chronic lymphocytic leukemia.

She is an experienced clinical investigator and her research focus has been the development of combination therapies that include chemoimmunotherapy, immunomodulatory drugs, novel kinase inhibitors and monoclonal antibodies. She also is working to find active, safer therapies for older patients with these diseases.

She earned her medical degree from Albert Einstein College of Medicine and completed her fellowship in Hematology-Oncology at Memorial Sloan-Kettering Cancer Center.

Academic Titles

  • Associate Professor of Medicine at CUMC

Hospital Affiliations

  • NewYork-Presbyterian/Columbia

Gender

  • Female

Insurance Accepted

Aetna

  • EPO
  • HMO
  • Indemnity
  • Medicare Managed Care
  • NY Signature
  • POS
  • PPO
  • Signature Administrators
  • Student Health

Affinity

  • Access (Exchange)
  • Essential Plan
  • Medicaid Managed Care
  • Medicare Managed Care

Amida Care

  • Special Needs Plan

Cigna

  • EPO
  • Great West
  • HMO
  • POS
  • PPO

Emblem/GHI

  • HMO
  • Medicare Managed Care
  • PPO

Emblem/HIP

  • ConnectiCare
  • EPO
  • Essential Plan
  • HMO
  • Medicaid Managed Care
  • Medicare Managed Care
  • POS
  • PPO
  • Select Care (Exchange)
  • Vytra

Empire Blue Cross Blue Shield

  • Blue Priority
  • EPO
  • HMO
  • Indemnity
  • Medicare (Mediblue)
  • NYP Employee Plan
  • Pathway (Exchange)
  • POS
  • PPO

Empire Blue Cross Blue Shield HealthPlus

  • Child/Family Health Plus
  • Essential Plan
  • Medicaid Managed Care

Fidelis Care

  • Child/Family Health Plus
  • Medicaid Managed Care
  • Medicare Managed Care

Healthfirst

  • Child/Family Health Plus
  • Medicaid Managed Care
  • Medicare Managed Care

Local 1199

  • Local 1199

MagnaCare

  • MagnaCare

Medicare

  • Traditional Medicare (NY)

Multiplan

  • Multiplan

Oxford Health Plans

  • Freedom
  • Liberty
  • Medicare Managed Care

POMCO

  • POMCO

UnitedHealthcare

  • Columbia University Employee Plan
  • Compass (Exchange)
  • EPO
  • Essential Plan
  • HMO
  • Medicaid (Community Plan)
  • Medicare Managed Care
  • POS
  • PPO
  • The Empire Plan (NYSHIP)

VNSNY CHOICE

  • SelectHealth

WellCare

  • Medicaid Managed Care
  • Medicare Managed Care

*Please contact the provider’s office directly to verify that your particular insurance is accepted.

Contact & Locations

1
161 Fort Washington Avenue
Garden Level
New York, New York 10032
Phone: (212) 305-5098
Fax:
(212) 305-8112
Primary

Research

Grants

A PHASE 2 OPEN-LABEL STUDY OF THE EFFICACY AND SAFETY OF ABT-199 (GDC-0199) IN CHRONIC LYMPHOCYTIC LEUKEMIA SUBJECTS WITH RELAPSE OR REFRACTORY TO B-CELL RECEPTOR SIGNALING PATHWAY INHIBITOR THERAPY (P&S Industry Clinical Trial)

Nov 20 2014 - Nov 20 2019

A STUDY OF IPI-145 AND OFATUMUMAB IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA PREVIOUSLY ENROLLED IN STUDY IPI-145-07 (P&S Industry Clinical Trial)

Aug 4 2014 - Aug 4 2019

A MULTICENTER, PHASE III, OPEN-LABEL, RANDOMIZED STUDY IN RELAPSED/REFRACTORY PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA TO EVALUATE THE BENEFIT OF GDC-0199 (ABT-199) PLUS RITUXIMAB COMPARED WITH BENDAMUSTINE PLUS RITUXIMAB (P&S Industry Clinical Trial)

Aug 1 2014 - Aug 1 2019

A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY EVALUATING THE EFFICACY AND SAFETY OF IDELALISIB IN COMBINATION WITH BENDAMUSTINE AND RITUXIMAB FOR PREVIOUSLY UNTREATED CHRONIC LYMPHOCYTIC LEUKEMIA (P&S Industry Clinical Trial)

Jul 15 2014 - Jul 15 2019

PHASE 3 STUDY OF IPI-145 VERSUS OFATUMUMAB IN PATIENTS WITH RELAPSED OR REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA (P&S Industry Clinical Trial)

Jun 24 2014 - Jun 24 2019